LivaNova plc Stock
Price
Target price
?
?
0.000%
-
0.000%
€57.62
10:03 / Stuttgart Stock Exchange
WKN: A14156 / Symbol: LIVN / Name: LivaNova / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
LivaNova plc Stock
There is no change in the price for LivaNova plc today.
LivaNova plc is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
With a current price of 57.0 € LivaNova plc is right around the predicted target price of 57 €.
Pros and Cons of LivaNova plc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | 0.000% | 2.727% | 5.607% | 26.116% | 7.619% | 13.000% | -1.739% |
| Haemonetics Corp. | 2.470% | 0.826% | -25.496% | - | -28.759% | - | - |
| Neogen Corp. | -1.580% | - | - | - | - | - | - |
| Merit Medical Systems | 0.000% | 2.239% | -2.143% | -33.495% | -7.432% | 6.202% | 40.947% |
Comments
LivaNova (NASDAQ:LIVN) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Stifel Nicolaus from $65.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $81.00 price target on the stock.
Show more
Ratings data for LIVN provided by MarketBeat

